^
    Back
    Association details:
    Biomarker:KHDRBS3 overexpression
    Cancer:Ovarian Cancer
    Drug:paclitaxel (Tubulin inhibitor)
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: D – Preclinical
    Source:
    Life Sci
    Title:

    KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG/CLDN6 signaling in epithelial ovarian cancer

    Published date:
    01/17/2022
    Excerpt:
    Here, we investigate the role of KHDRBS3 in glycolysis and increased resistance to PTX. The expression of KHDRBS3 was up-regulated in PTX-resistant cells.
    DOI:
    10.1016/j.lfs.2022.120328